You're signed outSign in or to get full access.
Vestal Point Capital, LP
Vestal Point Capital, LP is an investment advisory firm headquartered in New York, NY. Incorporated in Delaware with a central location in Manhattan, the firm reports through SEC filings and is operated by Chief Investment Officer and Managing Partner Ryan Wilder. While public sources confirm its existence, SEC registration, and location, no marketing or detailed strategy materials are published. Employee count and further operational details are not disclosed in public filings.
Investment Strategy
Vestal Point Capital, LP's specific investment strategy is not detailed in public filings. As the firm files Form 13F as an institutional investment manager, it likely manages portfolios of publicly traded securities for clients, but no further specifics about approach, focus areas, or investment philosophy are available via public sources.
Latest 13F Filing Activity
Vestal Point Capital, LP filed their most recent 13F report on Jun 30, 2025 disclosing 72 equity positions with a total 13F market value of $2B. The fund increased holdings in Jazz Pharmaceuticals PLC, Alcon AG, Revolution Medicines Inc. among other positions. Vestal Point Capital, LP reduced exposure to Insmed Inc., Urogen Pharma LTD, Ultragenyx Pharmaceutical Inc. among others.
Top Holdings
Equity Positions (72)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
A ACLX | Arcellx Inc | 9.53% | $181.1M | 2,750,000 | $63.73 | $65.85 | +$24.5M |
J JAZZ | Jazz Pharmaceuticals PLC | 6.70% | $127.3M | 1,200,000 | $106.12 | $106.12 | +$127.3M |
C CYTK | Cytokinetics Inc | 5.18% | $98.3M | 2,975,000 | $57.90 | $33.04 | -$5.8M |
N NUVL | Nuvalent Inc | 4.32% | $82.0M | 1,075,000 | $75.03 | $76.30 | +$5.8M |
V VERA | Vera Therapeutics Inc | 3.85% | $73.0M | 3,100,000 | $30.27 | $23.56 | +$13.0M |
Industry Allocation
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more